elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36579737-D0C139EC-9179-4662-BAE6-DD709FB477C4
Q36579737-D0C139EC-9179-4662-BAE6-DD709FB477C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36579737-D0C139EC-9179-4662-BAE6-DD709FB477C4
Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules
P2860
Q36579737-D0C139EC-9179-4662-BAE6-DD709FB477C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36579737-D0C139EC-9179-4662-BAE6-DD709FB477C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91347c83b6b396c8f56ea1310e46e9226c253128
P2860
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.